PatientsVille.com Logo


Amox Medical Research Studies

Up-to-date List of Amox Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Amox Medical Research Studies

Rank Status Study
1 Unknown  The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children
Condition: Functional Gastrointestinal Disorders
Interventions: Drug: Amoxicillin;   Other: Placebo
Outcome Measures: Induction of phase III of the migrating motor complex;   Characteristics of the induced phase III of the migrating motor complex;   Patient demographics;   Adverse events after study drug administration
2 Recruiting Antibiotic Prophylaxis - Amoxicillin
Condition: Healthy
Intervention: Drug: Amoxicillin
Outcome Measures: Quantitative and qualitative changes in the oral microflora will be determined as well as changes is susceptibility to amoxicillin among these commensals.;   Concentration of amoxicillin in saliva after one dose administration of amoxicillin
3 Recruiting A New Antibiotic Prophylaxis Regimen to Prevent Bacteremia Following Dental Procedures
Condition: Bacteremia
Interventions: Drug: Amoxicillin-Potassium Clavulanate;   Drug: Amoxicillin;   Drug: Chlorhexidine
Outcome Measures: Number of participants receiving a prophylactic dosage with amoxicillin-clavulanate i.v. with bacteremia following dental extractions;   Number of participants receiving a prophylactic dosage with amoxicillin i.v. (following the American Heart Association´s guidelines) with bacteremia after dental extractions
4 Unknown  Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia
Condition: Community Acquired Pneumonia
Interventions: Drug: Moxifloxacin;   Drug: Ampicillin;Amoxicillin
Outcome Measures: Proof of the clinical non inferiority by the cure rate at the treatment of a Pneumonia at the therapy end (round 3: Day 7 to 10) with a standard penicillin in a high dosage;   clinical cure rate;   bacteriological effectiveness on patients and seed level;   bacteriological sensitivity into-vitro;   time up to the drug-switch;   time until the dismissal of the patients necessity of the gift of additional antibacterial drug;   cost reduction of the antibiotic-therapy and the complete treatment;   assessment of the effectiveness by the investigator
5 Recruiting Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients
Condition: Infection During Hemodialysis
Interventions: Drug: Administration of Amoxicillin / clavulanic acid;   Drug: Ampicillin / sulbactam;   Procedure: Blooddraws for pharmacokinetic profiling
Outcome Measure: Influence of hemodialysis on the area under concentration curve of ampicillin/sulbactam and amoxicillin / clavulanic acid plasma concentration levels.
6 Recruiting Pharmacokinetics of Small Spectrum Beta-lactam Antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) in Patients on Intensive Care Units
Condition: Infection
Outcome Measures: Area under the serum concentration versus time curve (AUC) of Amoxicillin/Clavulanic acid.;   Area under the serum concentration versus time curve (AUC) of Cefuroxime.;   Severity of disease classification.;   Rate of organ failure.;   Concentration serum creatinin;   24 hour urine creatinine clearance;   Change in fluid balance;   Concentration serum albumin
7 Recruiting Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: pantoprazole, amoxicillin, clarithromycin, metronidazole;   Drug: pantoprazole, amoxicillin, clarithromycin, metronidzole
Outcome Measure: Comparison of the eradications rates of sequential therapy versus concomitant therapy of treatment of Helicobacter pylori infection in Korea.
8 Unknown  Effects of the Variation in the Time of Systemic Administration of Metronidazole and Amoxicillin Associated to the Non-surgical Therapy of Chronic Periodontitis.
Conditions: Chronic Periodontitis;   Clinical and Microbiological Effects
Intervention: Drug: Administration of Metronidazole plus Amoxicillin
Outcome Measures: - Mean change in clinical attachment level (CAL);   - Mean change in probing pocket depths (PD)
9 Recruiting Concomitant Therapy of H. Pylori
Condition: Gastritis, Gastric Ulcer, and Duodenal Ulcer
Intervention: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole
Outcome Measure: Evaluation of the efficacy of concomitant therapy for eradication of Helicobacter pylori
10 Recruiting Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: 7-day quadruple therapy;   Drug: 10-day sequential therapy;   Drug: 7-day standard triple therapy
Outcome Measure: eradication rate
11 Recruiting Efficacy of Amoxicilline/Clavulanic Acid in Patients Affected by Tic Disorder Colonized by Group A Streptococcus
Condition: Tic Disorders
Interventions: Drug: Amoxicillin-Potassium Clavulanate Combination;   Drug: placebo
Outcome Measure: Severity of tic disorder
12 Not yet recruiting Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term
Condition: Perineal Wound Infection
Interventions: Drug: Amoxicillin;   Drug: Placebo
Outcome Measure: Incidence of perineal wound infection
13 Recruiting RCT: Triple vs Sequential vs Concomitant Therapy H Pylori
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: 10 day triple therapy;   Drug: 10 day sequential therapy;   Drug: 10 day concomitant therapy
Outcome Measure: H pylori eradication rate
14 Recruiting Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy
Condition: Eradication Rates of the Two Regimens
Interventions: Drug: D1-D5: (lansoprazole + amoxicillin ) D6-D10: (lansoprazole+clarithromycin +metronidazole);   Drug: D1-D14: (lansoprazole + clarithromycin + amoxicillin)
Outcome Measures: Eradication rate according to Intention to treat (ITT) and per-protocol (PP) analysis;   Incidence of adverse effects
15 Recruiting 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication
Condition: Helicobacter Pylori Infection
Intervention: Drug: PPI, amoxicillin, metronidazole and clarithromycin
Outcome Measures: "Intention to treat" eradication rates;   " Per protocol" eradication rate;   Treatment compliance;   Number of participants with adverse events
16 Recruiting Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy Due to Acute Cholecystitis. Is it Necessary?
Condition: Acute Cholecystitis
Interventions: Drug: Amoxicillin clavulanic;   Drug: Placebo
Outcome Measures: Incidence of infectious postoperative complications;   Number of days of hospital stay or readmissions.;   Number of surgical reinterventions or reoperations.
17 Recruiting The SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children
Condition: Urinary Tract Infections
Interventions: Drug: Trimethoprim sulfamethoxazole, amoxicillin-clavulanate, cefixime, or cephalexin;   Drug: Placebo
Outcome Measures: Occurrence of treatment failures between short-course and standard-course therapies;   Occurrence of recurrent infections;   Occurrence of colonization with antimicrobial resistant bacteria;   Occurrence of asymptomatic bacteriuria;   Occurrence of clinical symptoms;   Occurrence of positive urine cultures
18 Recruiting Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract
Conditions: Vesicoureteral Reflux;   Renal Hypodysplasia, Nonsyndromic, 1;   Chronic Kidney Disease
Interventions: Drug: nitrofurantoin;   Other: No prophylaxis;   Drug: Amoxicillin-Potassium Clavulanate Combination;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Cefixime
Outcome Measures: urinary tract infections rate;   febrile urinary tract infections;   renal scars;   serum creatinine (renal function);   hypertension;   proteinuria;   body mass index;   serum cystatin C (renal function)
19 Unknown  Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
Conditions: Helicobacter Pylori Infection;   Chronic Gastritis
Interventions: Drug: esomeprazole;   Drug: moxifloxacin;   Drug: amoxicillin
Outcome Measures: Efficacy of a combination of esomeprazole (E), moxifloxacin (M) and amoxicillin (A) for third line therapy of H. pylori infection.;   Comparison of EMA 7 days versus EMA 14 days. Hypothesis: superiority of EMA 14 days 4 weeks after end of eradication therapy;   Tolerability,safety, post treatment resistance, influence of host genetics (CYP status) and pathogenicity factors of H. pylori on treatment success.
20 Not yet recruiting Comparison Between Two Different Antibiotic Regimens for the Placement of Dental Implants
Condition: Dental Implants
Intervention: Drug: Amoxicillin
Outcome Measures: Implants survival rate;   Patients' pain experience;   Patients' experience of interference with their daily activities;   Surgeons' perception of healing

These studies may lead to new treatments and are adding insight into Amox etiology and treatment.

A major focus of Amox research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Amox